Blog
Blogs from AHA leaders and members on the latest health care issues.
Antibiotic resistance – when bacteria stop responding to the drugs designed to kill them – may be the single most important infectious disease threat of our time. We risk turning back the clock to a world where simple infections can kill people as they did a century ago. Already more than 2 million…
America’s hospitals honor the service of our nation’s veterans and work to provide high-quality care for those who have served in the armed forces. Working closely with our partners in the Veterans Administration (VA) health system, hospitals strive to address any unique needs veterans may have…
There is a little-known – but critical – law that helps ensure hospitals are able to care for their communities. It is a ban on physician self-referral to hospitals in which they have an ownership interest. A permanent ban was put into effect in 2010 and eliminating it would raise the federal…
Saving an estimated 50,000 lives and $12 billion in health care costs is something to celebrate. Congratulations to the 3,700 acute-care hospitals that have participated in one of the Hospital Engagement Networks (HENs) that are part of the Centers for Medicare & Medicaid Services’ Partnership…
The AHA is proud to support National Apprenticeship Week, November 2-6, sponsored by the Department of Labor (DOL).
Open enrollment in the Health Insurance Marketplace has begun and hospitals are geared up to continue the important work of making the enrollment process easy, accessible and widely available. Now through the end of open enrollment on January 31, 2016, hospitals will host health fairs and…
A July 6 Government Accountability Office (GAO) report examining Medicare Part B spending at hospitals participating in the 340B Drug Pricing Program draws unsubstantiated conclusions about a program that has a proven track record of improving access to care for poor patients and vulnerable…
A report paid for by a group backed by the pharmaceutical industry is the latest in a series of attempts to misrepresent a program that has a proven track record of helping poor patients and vulnerable communities.
A new report ;by the Berkley Research Group (BRG) is the latest attempt by the pharmaceutical industry to disparage a program with a proven track record of helping poor patients and vulnerable communities.
The 340B program accounts for only two percent of the $325 billion in annual drug purchases made in the U.S., or roughly $6.5 billion. Hospitals participating in the 340B program provided $28.4 billion in uncompensated care in 2012; in other words, four times the drug purchase amount.